Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.54
-1.09 (-2.00%)
At close: Nov 4, 2024, 4:00 PM
53.75
+0.21 (0.39%)
After-hours: Nov 4, 2024, 7:55 PM EST
Moderna Revenue by Segment
History
| Date | Product Sales | Grant and Collaboration |
|---|---|---|
| Jun 30, 2024 | 4.90B | 149.00M |
| Mar 31, 2024 | 5.01B | - |
| Dec 31, 2023 | 6.67B | 177.00M |
| Sep 30, 2023 | 8.77B | 384.00M |
| Jun 30, 2023 | 10.14B | 554.00M |
| Mar 31, 2023 | 14.37B | 721.00M |
| Dec 31, 2022 | 18.47B | 828.00M |
| Sep 30, 2022 | 20.51B | 879.00M |
| Jun 30, 2022 | 22.20B | 794.00M |
| Mar 31, 2022 | 21.87B | 733.00M |
| Dec 31, 2021 | 17.68B | 796.00M |
| Sep 30, 2021 | 10.94B | 890.22M |
| Jun 30, 2021 | 6.13B | 889.13M |
| Mar 31, 2021 | 1.93B | 799.13M |
| Dec 31, 2020 | 199.87M | 603.52M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.